Shopping Cart
Remove All
Your shopping cart is currently empty
Apraclonidine hydrochloride (ALO 2145) is an α2-adrenergic agonist and a weak α-1 adrenergic receptor agonist. Apraclonidine hydrochloride lowers intraocular pressure in human eyes and can be used in studies about glaucoma therapy.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | $44 | - | In Stock | |
| 25 mg | $80 | - | In Stock | |
| 50 mg | $118 | - | In Stock | |
| 100 mg | $177 | - | In Stock | |
| 200 mg | $248 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $30 | - | In Stock |
| Description | Apraclonidine hydrochloride (ALO 2145) is an α2-adrenergic agonist and a weak α-1 adrenergic receptor agonist. Apraclonidine hydrochloride lowers intraocular pressure in human eyes and can be used in studies about glaucoma therapy. |
| In vitro | Apraclonidine hydrochloride penetrates the cornea and blood-brain barrier to a lesser extent[2]. |
| In vivo | Apraclonidine hydrochloride elevats intraocular pressure as well as glaucoma. Apraclonidine reduces aqueous humor synthesis and vasoconstrictor actions at the anterior segment branches of the ophthalmic artery[2]. Apraclonidine (1.15%) causes a 98% inhibition of PGE2-induced aqueous flare elevationy[3]. |
| Synonyms | P-aminoclonidine, Iopidine, Apraclonidinum, Apraclonidine HCl, Apraclonidina, ALO 2145, 4-Aminoclonidine |
| Molecular Weight | 281.57 |
| Formula | C9H11Cl3N4 |
| Cas No. | 73218-79-8 |
| Smiles | Cl.Nc1cc(Cl)c(NC2=NCCN2)c(Cl)c1 |
| Relative Density. | 1.63 g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 112.5 mg/mL (399.5 mM), Sonication is recommended. H2O: 11.2 mg/mL (39.78 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (14.21 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.